Mangoceuticals, Inc. (MGRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.45M |
| Enterprise Value | 6.27M |
| P/E Ratio | -0.33 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 20.72 |
| Price/Book Ratio | 0.53 |
| Enterprise/Revenue | 21.03 |
| Enterprise/EBITDA | -0.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -47.91 |
| Operating Margin | -41.85 |
AD
Management Effectiveness
| Return On Assets | -1.07 |
| Return On Equity | -1.06 |
Income Statement
| Revenue | 456,021 |
| Revenue/Share | 0.02 |
| Gross Profit | 250,386 |
| EBITDA | -18.82M |
| Net Income | -20.64M |
| Diluted EPS | -2.17 |
Balance Sheet
| Total Cash | 228,688 |
| Total Cash/Share | 0.01 |
| Total Debt | 324,151 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 0.18 |
| Book Value Per Share | 0.73 |
Price History
| 52-Week Change | -81.92 |
| 52-Week High | 2.75 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.44 |
| Moving Average 200 Days | 0.52 |
Statistics
| Average Volume | 13.78M |
| Shares Outstanding | 16.97M |
| % Held by Institutions | 7.05 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.04 |
| Last Split Factor | 1:15 |
| Last Split Date | October 16, 2024 |
AD
